InsiderTrades

Form 4 for PASG Passage BIO, Inc.

Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001209191-21-069101 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-10 2021-12-08 PASG Quigley Jill M. COO M - OptEx $0.23 +72.0K 368.8K +24% +$16.6K
DM 2021-12-10 2021-12-08 PASG Quigley Jill M. COO M - OptEx $0.00 -72.0K 27.6K -72% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-08 M A 71,975 $0.23 368,754 D — — (F1) Includes 367,259 of common stock, of which 88,488 shares are unvested and subject to repurchase by the Issuer if the reporting person ceases to provide services to the Issuer prior to the vesting of the shares. (F2) Includes 1,495 shares acquired under the 2020 Employee Stock Purchase Plan on May 14, 2021.
2 Derivative Employee Stock Option (right to buy) 2021-12-08 M D 11,193 $0.00 3,729 D $0.23 · — to 2029-02-06 11,193 Common Stock (F3) The option vested as to 25% of the total shares on November 12, 2019 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on November 12, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
3 Derivative Employee Stock Option (right to buy) 2021-12-08 M D 60,782 $0.00 27,626 D $0.23 · — to 2029-02-06 60,782 Common Stock (F4) The option vests as to 25% of the total shares on May 8, 2020 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on May 8, 2023 subject to the reporting person's provision of service to the issuer on each vesting date.